Business - Pharmaceutical

WASHINGTON - The Senate rejected a plan Tuesday to allow Americans to import low-cost prescriptions from abroad, handing drug makers a victory that may help secure passage of President Barack Obama's health care overhaul. Full Story »

GAITHERSBURG, Md. - Federal health advisers said Tuesday that expanded use of AstraZeneca's cholesterol pill Crestor can benefit patients with healthy cholesterol levels by preventing heart attack, stroke and death. Full Story »

BERKELEY HEIGHTS, N.J. - Cyclacel Pharmaceuticals Inc. said Tuesday its shares could be delisted from Nasdaq because the company does not comply with the exchange's $10 million minimum shareholder equity requirement. Full Story »

NEW YORK - The Nasdaq Stock Market on Monday said it will delist the stocks of three small companies: Teton Energy Corp., Altus Pharmaceuticals Inc., and UCBH Holdings Inc. Full Story »

NEW YORK - Teva Pharmaceutical Industries Ltd. said Monday U.S. health regulators scaled back dietary and health restrictions on its Parkinson's Disease drug Azilect. Full Story »

WASHINGTON - Senate Democratic leaders struggled Monday to get President Barack Obama's health care overhaul on track for passage by Christmas, faced with moderates' opposition to expanding Medicare and internal party disputes over abortion and importing cheaper prescription drugs. Full Story »

WASHINGTON - Federal health regulators say OSI Pharmaceutical's Tarceva slows the progression of lung cancer and extends patients' lives when used as a follow-up to chemotherapy. Full Story »

WASHINGTON - Shares of drug research contractor Pharmaceutical Product Development Inc. rose Monday on analyst expectations for increased contract bookings. Full Story »

INDIANAPOLIS - Drugmaker Eli Lilly & Co. said Monday regulators have approved a longer-lasting version of its top-selling drug, the anti-psychotic Zyprexa. Full Story »

LEXINGTON, Mass. - Cubist Pharmaceuticals Inc. said Monday it will pay $92.5 million in cash to buy biopharmaceutical company Calixa Therapeutics Inc. in a deal it expects to close this month. Full Story »

UNION CITY, Calif. - Questcor Pharmaceuticals Inc. said Friday it appointed Louis Silverman, CEO of Marina Medical Billing Service Inc., to its board. Full Story »

Shares of IMS Health Inc. tumbled Friday, a day after an amendment was introduced to the Senate health care overhaul bill that would effectively ban pharmaceutical data mining. Full Story »

NEW YORK - AstraZeneca said Thursday a high dose of its drug Faslodex reduced the risk of breast cancer progressing by 20 percent in patients during a late-stage study. Full Story »

NEW YORK - Shares of China Nuokang Bio-Pharmaceutical Inc. fell nearly 4 percent in their trading debut Thursday after pricing at $9 per American depositary share, below their expected range. Full Story »

INDIANAPOLIS - Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dropped as its 2009 forecast fell short of Wall Street expectations. Full Story »

TUSTIN, Calif. - Peregrine Pharmaceuticals Inc. said Thursday it cut its 2010 fiscal second-quarter loss nearly in half as revenue from manufacturing services and government payments for the antivirus drug candidate bavituximab increased sharply. Full Story »

WASHINGTON - Two Democratic senators want to stop drug companies from mining pharmacy records to see which doctors are prescribing their medications. Full Story »

HASBROUCK HEIGHTS, N.J. - Drug developer Nymox Pharmaceutical Corp. said Thursday it has obtained a commitment for $15 million in equity financing from institutional investors. Full Story »